Recent Developments in Aortic Valve Replacement

Recent Developments in Aortic Valve Replacement

A new era in aortic treatment is off to messy start as debate over just how dispersed aortic valve replacement (TAVR) be throughout the U. ," said CMS Administrator Verma in press announcing the new Recent Developments in National Determination for TAVR.

Both Evolut R and Evolut PRO, as well Sapien 3, received the expanded indication in today’s eagerly awaited announcement. (UPDATED) The US Food and Drug Administration has approved an expanded indication for the self-expanded Evolut series (Medtronic) and the balloon-expandable Sapien 3 and Sapien Ultra (Edwards Lifesciences) transcatheter heart valves for the treatment of patients with severe aortic stenosis at low risk for surgery. The valves are now approved across the entire spectrum of risk, including patients ineligible for bicuspid aortic valve stenosis surgery, those at high or intermediate risk, and—as of today—those at low risk. The expanded indication for the Medtronic devices is based on the results from the Evolut Low-Risk trial published earlier this year in the New England Journal of Medicine and presented at the American College of Cardiology (ACC) 2019 Scientific Sessions. In that study, investigators led by Michael Reardon, MD (Houston Methodist DeBakey Heart and Vascular Center, TX), randomized 1,468 patients to TAVR or to surgery.

NEW ORLEANS — Patients with aortic valves who underwent aortic valve replacement with balloon-expandable valve had similar death and stroke 1 year, FDA Expands TAVR according to data highlighted the College Cardiology Scientific At 30 days, the group had higher stroke than the group. “Based on Raj Makkar, associate director Cedars-Sinai Heart Institute and member the Cardiology Intervention Editorial Board, said press release. study supports the notion carefully selected Balloon-expandable TAVR safe patients with aortic stenosis can avoid and be treated with less invasive option.

Comments

Popular posts from this blog

His first job was training service dogs in prison. The dogs go on to transform veterans’ lives.

GMIT student wins multiple national awards for heart disease research

Heart patient to Ironman in just 16 months